Dr Feryal Akay | Biomaterials | Best Researcher Award

Dr Feryal Akay | Biomaterials | Best Researcher Award

Dr. Feryal Akay is a PhD graduate in Chemistry from Dicle University (2023), specializing in human immunoglobulin G glycation and the effects of Morus nigra leaf extract on DNA glycation. She has participated in key national projects and has contributed to high-impact publications in journals like Archives of Biochemistry and Biophysics (2025) and Indian Journal of Biochemistry and Biophysics (2024). With experience as an Ar-Ge specialist at Labixir, Dr. Akay is deeply committed to advancing glycation research and is a strong candidate for the Best Researcher Award. 📚🧬🌿

Dr Feryal Akay, University of Dicle, Turkey

Profile

ORCID

SCOPUS

Education🎓

Dr. Feryal Akay completed her PhD in Chemistry at Dicle University in 2023, with a thesis on the glycation of human immunoglobulin G and its impact on antigen binding, supervised by Prof. Dr. Göksel Kızıl and Prof. Dr. Beran Yokuş. She also earned her Master’s in Chemistry from the same university in 2018, focusing on the effects of Morus nigra leaf ethanol extract on DNA glycation. Dr. Akay completed her Bachelor’s degree in Chemistry in 2015 at Dicle University’s Faculty of Science. 🎓🧪📜

Experience🩺

Dr. Feryal Akay worked as an Ar-Ge (Research and Development) Specialist at Labixir, a pharmaceutical analysis laboratory, from November 2021 to August 2022. In this role, she contributed to various research and development projects, specializing in pharmaceutical analysis and innovative techniques in the field. Her work involved analyzing and improving the efficacy of pharmaceutical products, contributing to the advancement of the pharmaceutical industry. Dr. Akay’s experience in this commercial sector allowed her to apply her academic expertise in a practical, real-world environment, further enhancing her skill set in both research and pharmaceutical development. 💊🔬🧪

Certificate 🏅

Dr. Feryal Akay has earned several prestigious certificates for her participation in international conferences. She attended the 1st International Multidisciplinary Cancer Research Congress held at Dicle University in Diyarbakır from 18-22 September 2019. She also participated in the INESEC 2018, The International Engineering Natural Science Conference, from 14-17 November 2018. Additionally, Dr. Akay presented a Oral Presentation at the 6th International Congress on Pharmaceutical Chemistry in Antalya/Belek, held by Atatürk University and the Chemists Association, from 22-25 March 2018. 🏅🎓🌍📚

Research Focus 🔬

Dr. Feryal Akay’s research primarily focuses on glycation and its impact on immune function. Her studies explore how fructose-derived glycation affects antigen binding in human IgG and lymphocytes, aiming to better understand the role of glycation in immune responses (Archives of Biochemistry and Biophysics, 2025). Additionally, Dr. Akay has investigated the inhibitory effects of Morus nigra leaf extract on DNA glycation and its potential in preventing advanced glycation end products (Indian Journal of Biochemistry and Biophysics, 2024). Her work also includes the antiglycative effects of Capsicum annuum (chili) and pyridoxamine in experimental diabetes models (Revista Brasileira de Farmacognosia, 2023). 🌱🧬🔬

Publications📚

Fructose-derived glycation and immune function: Effects on antigen binding in human IgG and lymphocytes 🧬

  • Authors: Feryal Akay, Nesrin İnceören, Cemal Nas, Beran Yokuş, Göksel Kızıl, Murat Kızıl
  • Journal: Archives of Biochemistry and Biophysics

Evaluation of ethanol extract of Morus nigra L. as an inhibitory agent for DNA-Advanced glycation end product (DNA-AGEs) 🍃

  • Authors: Feryal Akay
  • Journal: Indian Journal of Biochemistry and Biophysics

Antiglycative Effect of Combination of Extracts of Capsicum annuum (chilli) and Pyridoxamine Against Glycation in Streptozotocin-induced Experimental Diabetes in Rats 🌶️

  • Authors: Nesrin İnceören, Feryal Akay, Cemal Nas, Engin Deveci, Göksel Kızıl, Murat Kızıl
  • Journal: Revista Brasileira de Farmacognosia

Determination Of Antioxidant Activity of Dietary Selenium, Oleuropein, Glutathione Mixture 🥗

  • Authors: Feryal Akay, Göksel Kızıl
  • Journal: European Journal of Technic

Dr Markus Laubach | Biomaterials | Best Researcher Award

Dr Markus Laubach | Biomaterials | Best Researcher Award

Dr Markus Laubach, LMU University Hospital Munich, Germany

Dr. Markus Laubach 🎓🩺 is a distinguished researcher in orthopaedics and medical innovation. Holding a Ph.D. in preclinical assessment of novel medical devices, an MBA in Healthcare Management, and certifications in emergency medicine, he combines clinical expertise with research excellence. 🏥🔬 His groundbreaking work focuses on scaffold-guided bone regeneration, 3D-printed implants, and bone grafting techniques, published in top journals like Biomaterials Science and Scientific Reports. 💡📚 Dr. Laubach has secured over EUR 350,000 in grants and won prestigious awards, including the Best Poster Award at DKOU 2023. 🌍 He actively collaborates globally, advancing orthopaedic trauma care. 🦴✨

Publication Profile

Orcid

Scopus

Education and Training🎓

Dr. Markus Laubach 🎓 began his educational journey at Stefan-George-Gymnasium, earning his Abitur in 2007 🎒. He trained as a paramedic 🚑 at Arbeiter-Samariter-Bund in 2008. He pursued Medicine 🩺 at Maastricht University (2010–2016) and earned his Dr. med. from Charité Berlin in 2019 📚, focusing on brain aging and executive functioning 🧠. Further, he specialized in Emergency Medicine 🚨 and completed his Ph.D. at QUT 🦴 (2020–2023), researching bone graft aspirator devices. Recently, he earned an MBA 🎓 in Health Care Management 🏥. Currently, he advances orthopaedic research at LMU Munich through the prestigious Feodor Lynen Fellowship 🌍.

Professional Experience💼

Dr. Markus Laubach 🩺 has extensive professional experience in orthopaedics and trauma surgery. He is currently a Resident at the LMU University Hospital 🏥, Musculoskeletal University Center Munich (2023–present). Previously, he worked as a Resident at RWTH Aachen University Hospital (2016–2020) 🦴, advancing his surgical expertise. Dr. Laubach further honed his skills in medtech commercialization through The BridgeTech Program 🌐 in Australia (2021–2022). His medical journey began as a Paramedic 🚑 with organizations like Malteser Hilfsdienst (2011–2016), Arbeiter Samariter Bund (2009–2010), and DRK Rettungsdienst GmbH (2008–2009), reflecting his dedication to emergency medical care and patient well-being 🤝.

Research Focus Area 🌱🧬

Markus Laubach is a researcher specializing in biomaterials, bone regeneration, and spinal surgery innovations. His work primarily focuses on advancing implants, scaffolds, and bone grafts for clinical applications, particularly in lumbar spinal fusion and bone defect treatments. He is involved in designing 3D printable, patient-specific bioresorbable bone scaffolds to promote bone regeneration. Laubach’s research extends to the development of novel bone graft harvesting techniques and the assessment of biodegradable interbody cages. His work intersects with orthopaedic trauma, regenerative medicine, and biomechanics. 🦴🧬🩺

Memberships

Dr. Markus Laubach is an active member of several prestigious medical and research organizations. He is affiliated with AO Trauma 🦵, focusing on advancing trauma care, and the Deutsche Gesellschaft für Orthopädie und Unfallchirurgie (DGOU) 🇩🇪, which promotes orthopedic and trauma surgery excellence. He also participates in the Gesellschaft für Extremitätenverlängerung und -rekonstruktion (GEVR) 🦴, dedicated to extremity reconstruction. Additionally, Dr. Laubach is a member of the Orthopaedic Research Society (ORS) 🔬 and the Tissue Engineering and Regenerative Medicine International Society (TERMIS) 🌍, contributing to cutting-edge research in tissue engineering and regenerative medicine.

Awards🏆

Dr. Markus Laubach has received notable recognition for his scientific contributions. In 2023, he was awarded the Best Poster Award at the DKOU 2023 in Berlin 🏆. His research has attracted competitive grants, including EUR 182,022.36 from the Bundesministerium für Bildung und Forschung for a clinical study on tibial transverse callus distraction in diabetic foot ulcer patients 💉, and EUR 39,600 from the Feodor Lynen Return Fellowship 🏅. Dr. Laubach also secured funding from the Volkswagen Foundation (EUR 38,000) and Clive & Vera Ramaciotti Foundation (AUD 130,000) for innovative bone defect treatments using 3D-printed scaffolds.

Publication Top Notes📄✨

Advances in implants and bone graft types for lumbar spinal fusion surgery

Modular design workflow for 3D printable bioresorbable patient-specific bone scaffolds: extended features and clinical validation.

Preclinical assessment of a novel aspirator device for intramedullary bone graft harvesting

Lost in translation: the lack of agreement between surgeons and scientists regarding biomaterials research and innovation for treating bone defects

An innovative intramedullary bone graft harvesting concept as a fundamental component of scaffold-guided bone regeneration: A preclinical in vivo validation

Chirurg*innen vs. Wissenschaftler*innen – Mind the Gap! DKOU Science-Slam 2023: Umfragestudie zu Biomaterialien bei Knochendefekten [Surgeons vs. scientists—Mind the gap!: Survey study on biomaterials for bone defects]

How framing bias impacts preferences for innovation in bone tissue engineering

Semi-automated scaffold design workflow to facilitate clinical translation of scaffold guided bone regeneration

The development of a modular design workflow for 3D printable bioresorbable patient-specific bone scaffolds to facilitate clinical translation

Histological and Immunohistochemical Characterization of Osteoimmunological Processes in Scaffold-Guided Bone Regeneration in an Ovine Large Segmental Defect Model

Conclusion

Dr. Markus Laubach’s robust academic foundation, exceptional research achievements, successful funding track record, and dedication to clinical translation make him an excellent candidate for the Best Researcher Award. His work directly addresses critical gaps in bone defect treatments, contributing both to scientific innovation and practical healthcare advancements.

Geung-Joo Lee | Biomaterials | Best Researcher Award

Geung-Joo Lee | Biomaterials | Best Researcher Award

Prof Geung-Joo Lee, Chungnam National University, South Korea

Prof. Geung-Joo Lee is a distinguished scientist specializing in genome editing, molecular breeding, and crop improvement 🌱. With a Ph.D. in Crop and Soil Science from the University of Georgia (USA) and over two decades of experience, he serves as a professor at Chungnam National University. His groundbreaking research includes CRISPR-Cas9 technologies, functional genomics, and cultivar development for crops like watermelon, melon, and camelina. 📚 Prof. Lee has published extensively in high-impact journals and holds leadership roles in professional organizations. His innovative work addresses global challenges in food security, sustainability, and plant science, exemplifying research excellence. 🌍✨

Publication Profile

Orcid

Scopus

Educational Background 🎓

Prof. Geung-Joo Lee boasts an impressive academic foundation 🌟. He earned his Ph.D. in Crop and Soil Science from the University of Georgia, USA, in December 2000 🎓, showcasing his expertise in plant science. Prior to this, he completed a Master of Science in Horticultural Science in February 1991 and a Bachelor of Science in Horticulture in February 1989, both from the prestigious Seoul National University, Korea 🌱. These academic achievements highlight his commitment to advancing knowledge in crop science and horticulture, forming the basis for his impactful research and contributions to the field of agriculture and biotechnology 🌍.

Professional Experience and Contributions 💼

Prof. Geung-Joo Lee has held a series of prestigious academic and research positions throughout his career 🌱. Since August 2011, he has been a Professor at the Dept. of Horticulture, Chungnam National University 🏫. Prior to that, he served as an Assistant Professor at Mokpo National University from March 2009 to July 2011. He also contributed as a Senior Researcher at the Advanced Radiation Technology Institute, KAERI from 2005 to 2009, specializing in mutation breeding and genetics 🔬. His postdoctoral research at the University of Missouri and the University of Georgia further solidified his expertise in agronomy and crop science 🌾.

Research Focus Area 🌱🧬

Prof. Geung-Joo Lee’s research primarily focuses on plant genomics and crop improvement 🌱. He specializes in genome editing techniques, including engineered nucleases and transformation, to enhance flower quality, disease resistance, plant morphology, and nutritional composition 🍅. His work on cultivar development spans various horticultural crops, including turfgrass, petunia, lily, and miscanthus 🌸. Prof. Lee also explores functional genomics, examining gene mechanisms, chromosomal locations, and gene networks 🔬. He is committed to studying functional horticultural crops such as halophytes and landraces, aiming to improve sustainability and adaptability in agriculture 🌾.

Professional Organizations 🌱✨

Prof. Geung-Joo Lee is an active member of several prestigious professional organizations 🌍. He is part of the International Society for Horticultural Sciences and the National Associations of Plant Breeders, contributing to global discussions in plant science 🌱. In Korea, he holds key roles, serving as Secretary of General Affairs and Field Editor for Breeding & Genetics in the Korean Society of Horticultural Science. He is also an Associate Editor for Breeding Science of Korea 🖋️ and currently serves as the President of the Korean Society of Turfgrass Science, leading advancements in turfgrass research 🌾.

Publication Top Notes 📄✨

Leaf Area Prediction of Pennywort Plants Grown in a Plant Factory Using Image Processing and an Artificial Neural Network

Optimized Regeneration of Petunia Protoplast and Its Association with Tissue Identity Regulators

Genetic Dissection of CRISPR-Cas9 Mediated Inheritance of Independently Targeted Alleles in Tobacco α-1,3-Fucosyltransferase 1 and β-1,2-Xylosyltransferase 1 Loci

Optimization of Protoplast Isolation from Leaf Mesophylls of Chinese Cabbage (Brassica rapa ssp. pekinensis) and Subsequent Transfection with a Binary Vector

Novel genes in response to varying water deficit in oil crop Camelina sativa

Genome-wide identification, functional prediction and expression profiling of long non-coding RNAs in Camelina sativa

In vitro screening for Botrytis leaf blight resistance in Lilium species

Reduced ethylene production in tomato fruits upon CRSPR/Cas9-mediated lemads-rin mutagenesis

Conclusion🔍

Prof. Geung-Joo Lee’s extensive research portfolio, global collaborations, leadership roles, and impactful publications make him a highly suitable and deserving candidate for a Best Researcher Award. His work exemplifies innovation and excellence, with profound implications for agriculture, food security, and biotechnology.